Association between circulating monocytes and coronary plaque progression in patients with acute myocardial infarction

Circulation Journal

Volumn 74, Issue 7, 2010, Pages 1384-1391

  Nozawa, Naoki ^a   Hibi, Kiyoshi ^a   Endo, Mitsuaki ^a   Sugano, Teruyasu ^b   Ebina, Toshiaki ^a   Kosuge, Masami ^a   Tsukahara, Kengo ^a   Okuda, Jun ^a   Umemura, Satoshi ^b   Kimura, Kazuo ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Blood cells; Circulating monocytes; Intravascular ultrasound; Plaque

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ARTERIAL CIRCULATION; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN CELL; INTRAVASCULAR ULTRASOUND; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PREDICTION; RESTENOSIS; REVASCULARIZATION; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD CELL COUNT; CORONARY ARTERY DISEASE; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HEART INFARCTION; MIDDLE AGED; OBSERVATION; PATHOLOGY; PREDICTIVE VALUE;

AGED; BLOOD CELL COUNT; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; OBSERVATION; PREDICTIVE VALUE OF TESTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77954477922     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0779     Document Type: Article

References (46)

1. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-809.
2. Gerrity RG. The role of the monocyte in atherogenesis. I: Transition of blood-borne monocytes into foam cells in fatty lesion. Am J Pathol 1981; 103: 181-190.
3. Gerrity RG. The role of the monocyte in atherogenesis. II: Migration of foam cells from atherosclerotic lesion. Am J Pathol 1981; 103: 191-200.
4. Sanz J, Moreno PR, Fuster V. Update on advances in atherothrom-bosis. Nat Clin Pract Cardiovasc Med 2007; 4: 78-89.
5. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, et al. Ly-6C monocytes dominate hypercholester-olemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007; 117: 195-205.
6. Leibovich SJ, Ross R. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol 1976; 84: 501-514.
7. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger B. Regulation of differential properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990; 10: 966-990.
8. Rosenfeld M, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercho-lesterolemic fat-fed rabbits. Arteriosclerosis 1990; 10: 680-687.
9. Schober A, Zernecke A. Chemokines in vascular remodeling. Thromb Haemost 2007; 97: 730-737.
10. Schmitz G, Grandl M. Lipid homeostasis in macrophages-implica-tions for atherosclerosis. Rev Physiol Biochem Pharmacol 2008; 160: 93-125.
11. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135 - 1143.
13. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
14. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685 - 1695.
15. Yan ZQ, Hansson GK. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007; 219: 187-203.
16. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002; 8: 1235 - 1242.
17. Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int J Cardiol 2008; 130: 147-158.
18. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007; 204: 3037-3047.
19. Piek JJ, van der Wal AC, Meuwissen M, Koch KT, Chamuleau SA, Teeling P, et al. Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. J Am Coll Cardiol 2000; 35: 963-967.
20. Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004; 43: 18-23.
21. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003; 107: 690-695.
22. Kervinen H, Mänttäri M, Kaartinen M, Mäkynen H, Palosuo T, Pulkki K, et al. Prognostic usefulness of plasma monocyte/macro-phage and T-lymphocyte activation markers in patients with acute coronary syndromes. Am J Cardiol 2004; 94: 993-996.
23. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte che-moattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88:1121-1127.
24. Popma JJ, Gibson CM. Qualitative and quantitative angiography. In: Topol EJ, editor. Text book of interventional cardiology, 4th edn. Philadelphia: Saunders, 2003; 827-846.
25. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lower-ing therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080.
26. Takagi T, Okura H, Kobayashi Y, Kataoka T, Taguchi H, Toda I, et al. A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Piogli-tazone Study). J Am Coll Cardiol Intv 2009; 2: 524-531.
27. Olivares R, Ducimetiere P, Claude JR. Monocyte count: A risk factor for coronary heart disease? Am J Epidemiol 1993; 137: 49-53.
28. Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004; 35: 1619-1624.
29. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, et al. Monocyte Chemoattractant Protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19: 1518-1525.
30. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: Special reference to monocyte chemoattractant protein-1. Hypertension 2003; 41: 834-841.
31. Swirski FK, Pittet MJ, Kircher MF, Aikawa E, Jaffer FA, Libby P, et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA 2006; 103: 10340-10345.
32. Kircher MF, Grimm J, Swirski FK, Libby P, Gerszten RE, Allport JR, et al. Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 2008; 117: 388-395.
33. Tamura K, Nakajima H, Rakue H, Sasame A, Naito Y, Nagai Y, et al. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocar-dial infarction. Jpn Circ J 1999; 63: 357-361.
34. Tashiro H, Shimokawa H, Yamamoto K, Nagano M, Momohara M, Muramatu K, et al. Monocyte-related cytokines in acute myocardial infarction. Am Heart J 1995; 130: 446-452.
35. Wallentin L, Lagerqvist B, Husted S, Kontny F, Ståhle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomized trial. FRISC II Investigators. Lancet 2000; 356: 9-16.
36. Juul-Möller S, Edvardsson N, Jahnmatz B, Rosén A, Sørensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pec-toris: The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 1992; 340: 1421 - 1425.
37. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915-922.
38. Rioufol G, Finet G, Ginon I, André-Fouët X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 2002; 106: 804-808.
39. Guazzi MD, Bussotti M, Grancini L, De Cesare N, Guazzi M, Pera IL, et al. Evidence of multifocal activity of coronary disease in patients with acute myocardial infarction. Circulation 1997; 96: 1145 - 1151.
40. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347: 5-12.
41. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440-1445.
42. Kruk M, Przyluski J, Kalinczuk L, Pregowski J, Deptuch T, Kadziela J, et al, ANIN Myocardial Infarction Registry Group. Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty. Circ J 2008; 72: 205-211.
43. Chang LT, Chua S, Sheu JJ, Wu CJ, Yeh KH, Yang CH, et al. Level and prognostic value of serum myeloperoxidase in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J 2009; 73: 726-731.
44. Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T. Regression of coronary atherosclerosis by simvastatin: A serial intravascular ultrasound study. Circulation 2004; 110: 265-270.
45. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH Study. Circulation 2004; 110: 1061-1068.
46. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-1565.